Cargando…
From cholera to enterotoxigenic Escherichia coli (ETEC) vaccine development
It was shown earlier that immune responses against cholera toxin (CT) as well as Vibrio cholerae lipopolysaccharide (LPS) or whole bacterial cells (WC) were protective and that these different antibody specificities co-operated synergistically for protection against experimental cholera. Similarly,...
Autor principal: | Svennerholm, Ann-Mari |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3089050/ https://www.ncbi.nlm.nih.gov/pubmed/21415493 |
Ejemplares similares
-
Enterotoxigenic Escherichia coli (ETEC) vaccines: Priority activities to enable product development, licensure, and global access
por: Khalil, Ibrahim, et al.
Publicado: (2021) -
Shift in Phenotypic Characteristics of Enterotoxigenic Escherichia coli (ETEC) Isolated from Diarrheal Patients in Bangladesh
por: Begum, Yasmin Ara, et al.
Publicado: (2014) -
Expression of Colonization Factor CS5 of Enterotoxigenic Escherichia coli (ETEC) Is Enhanced In Vivo and by the Bile Component Na Glycocholate Hydrate
por: Nicklasson, Matilda, et al.
Publicado: (2012) -
Resistance Pattern and Molecular Characterization of Enterotoxigenic Escherichia coli (ETEC) Strains Isolated in Bangladesh
por: Begum, Yasmin A., et al.
Publicado: (2016) -
Identification and characterization of the novel colonization factor CS30 based on whole genome sequencing in enterotoxigenic Escherichia coli (ETEC)
por: von Mentzer, Astrid, et al.
Publicado: (2017)